 |
[5,10,15,20-tetrakis(1,3-diethylimidazolium-2-yl)porphyrinato] manganese(III)pentachloride |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2003-11-04 00:00:00 |
| Sponsor | Aeolus Pharmaceuticals, Inc.;PO Box 14287; 79 T.W. Alexander Dr., Suite 200;Research Triangle Park, North Carolina, 27709 |
